Tempest to Present Two Posters at the 2022 American Association for Cancer Research (AACR) Annual Meeting
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
News
TCR² Therapeutics to Highlight Off-the-Shelf TRuC-T Cell at the American Association of Cancer Research Annual Meeting 2022
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
Checkmate Pharmaceuticals to Present at the 2022 American Association for Cancer Research (AACR) Annual Meeting
CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) (“Checkmate”), a clinical stage biotechnology company…
IO Biotech Announces Acceptance of Abstract to be Presented at AACR Annual Meeting on April 8, 2022
Clinical Update from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab in Metastatic Melanoma…
Zentalis Pharmaceuticals to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2022
Updated data from Phase 1 expansion cohort of ZN-c3 in uterine serous carcinoma (USC) will…
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
ORIC-533 oral presentation and poster presentation to highlight potential of small molecule inhibitor of CD73…
Senti Bio to Present Preclinical Data on Cancer-Killing Allogeneic CAR-NK Cells at AACR Annual Meeting
– Abstract highlights the Company’s progress in applying gene circuits to improve the cytotoxicity and…
Statera Biopharma Announces Revised Preliminary Revenue and Financial Results of Fiscal Year 2021
FORT COLLINS, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the…
C4 Therapeutics to Present at the American Association for Cancer Research (AACR) Annual Meeting 2022Â
– Clinical Data from Cohort A of the Ongoing Phase 1/2 Trial of CFT7455, a…
NGM Bio Announces Oral and Late-Breaking Poster Presentations Supporting Its Myeloid Reprogramming Portfolio at Upcoming 2022 AACR Annual Meeting
Oral presentation to showcase NGM Bio’s in vitro and in vivo research demonstrating potential advantages…
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2022 and Recent Developments
— Recorded Third Quarter Revenue of $31.5 Million — — Myford South and Viral Vector…
Chinook Therapeutics to Present at Oppenheimer’s 32nd Annual Healthcare Conference
SEATTLE, March 08, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Brickell Biotech to Report Fourth Quarter and Full Year 2021 Financial Results and Provide a Corporate Update on March 15, 2022
BOULDER, Colo., March 08, 2022 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell” or the “Company”)…
AGTC to Participate in Upcoming Investor Conferences
GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 08, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:…
Shockwave Medical Named to Fast Company’s “Most Innovative Company” List
Pioneer of IVL Selected as the Second Most Innovative Medical Device Company SANTA CLARA, Calif.,…
Paratek Pharmaceuticals Announces the Publication of Data from an Investigator-Initiated Study of NUZYRA® (omadacycline) in a Hollow Fiber System Model Against Pulmonary Mycobacterium avium complex
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. announced today the publication of…
Xigem Technologies Provides Corporate Update
Toronto, Ontario–(Newsfile Corp. – March 8, 2022) – Xigem Technologies Corporation (“Xigem” or the “Company“)…
LBank Weekly Listing Report, 7th March 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – As a world class digital asset…
Evertz Technologies Reports Third Quarter Results for the Quarter Ended January 31, 2022.
Burlington, Ontario–(Newsfile Corp. – March 8, 2022) – Evertz Technologies Limited (TSX: ET), the leader…
LBank Exchange Will List KleeKai (KLEE) on March 9, 2022
Internet City, Dubai–(Newsfile Corp. – March 8, 2022) – LBank Exchange, a global digital asset…